[1]王晶郭晋源杨海龙李刚张云锋.益气强心汤结合西医综合治疗对慢性心力衰竭患者血管内皮功能、心功能的影响[J].现代中医药,2024,(03):058-62.[doi:10.13424/j.cnki.mtcm.2024.03.011]
　WANG JingGUO JinyuanYANG HailongLI GangZHANG Yunfeng.Effect of Yiqi Qiangxin Decoction Combined with Western MedicineComprehensive Treatment on Vascular Endothelial Functionand Cardiac Function in Patients with Chronic Heart Failure[J].Modern Traditional Chinese Medicine,2024,(03):058-62.[doi:10.13424/j.cnki.mtcm.2024.03.011]
点击复制

益气强心汤结合西医综合治疗对慢性心力衰竭患者血管内皮功能、心功能的影响()
分享到：

《现代中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2024年03期
页码:
058-62
栏目:
出版日期:
2024-05-20

文章信息/Info

Title:
Effect of Yiqi Qiangxin Decoction Combined with Western MedicineComprehensive Treatment on Vascular Endothelial Functionand Cardiac Function in Patients with Chronic Heart Failure
文章编号:
1672-0571(2024)03-0058-05
作者:
王晶1郭晋源1杨海龙1李刚1张云锋2
1.宝鸡高新医院，陕西 宝鸡 721000；
2.宜君县人民医院，陕西 宜君 727299
Author(s):
WANG Jing1GUO Jinyuan1YANG Hailong1LI Gang1ZHANG Yunfeng2
1.Baoji High tech Hospital，Shaanxi Baoji 721000，China；
2.Yijun County Peoples Hospital，Shaanxi Yijun 727299，China
关键词:
关键词：益气强心汤; 慢性心力衰竭; 血管内皮功能; 心功能; 随机对照
Keywords:
Key words:Yiqi Qiangxin decoction; Chronic heart failure; Vascular endothelial function; Heart function; Randomized controlled
分类号:
R256.2
DOI:
10.13424/j.cnki.mtcm.2024.03.011
文献标志码:
A
摘要:
摘要：目的 观察益气强心汤联合西医综合治疗对慢性心力衰竭患者心功能及血管内皮功能的影响。方法 选取宝鸡高新医院2020年3月—2022年5月接纳的慢性心力衰竭患者92例，随机分为对照组（46例，西医综合治疗）、联治组（46例，西医综合治疗+益气强心汤），测量比较治疗前后组间氧化应激指标、炎性因子、血管内皮功能指标、心功能指标水平差异，记录不良反应。结果 治疗后联治组超氧化物歧化酶（SOD）水平提升幅度更高，丙二醛（MDA）降幅更大（P＜0.05）；治疗后肿瘤坏死因子-α（TNF-α）、白介素-1β（IL-1β）比较，联治组更低（P＜0.05）；治疗后联治组内皮素-1（ET-1）水平显著低于对照组，一氧化氮（NO）水平显著高于对照组（P＜005）；治疗后联治组左心室收缩末期容积（LVESV）显著低于对照组，左心室射血分数（LVEF）显著高于对照组（P＜005）；给药期间两组患者不良反应发生率无显著差异（P＞0.05）。结论 慢性心力衰竭患者给予益气强心汤联合西医综合治疗可改善其炎症反应及氧化应激反应，减轻血管内皮损伤，恢复患者心功能，且基本不增加不良反应。
Abstract:
Abstract：Objective To analyze the effect of Yiqi Qiangxin decoction combined with Western medicine comprehensive treatment on the heart function and endothelial function of patients with chronic heart failure.Methods 92 patients with chronic heart failure admitted to Baoji High tech Hospital from March 2020 to May 2022 were randomly divided into a control group (46 cases，Western medicine comprehensive treatment) and a combination treatment group (46 cases，Western medicine comprehensive treatment+Yiqi Qiangxin decoction).The differences in levels of oxidative stress indicators，inflammatory factors，vascular endothelial function indicators，and cardiac function indicators between the groups before and after treatment were measured and compared，and adverse reactions were recorded.Results After treatment，the combined treatment group showed a higher increase in superoxide dismutase (SOD) levels and a greater decrease in malondialdehyde (MDA) levels (P<0.05)；After treatment，the levels of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) were lower in the combined treatment group (P<0.05)；After treatment，the level of endothelin-1 (ET-1) in the combined treatment group was significantly lower than that in the control group，and the level of nitric oxide (NO) was significantly higher than that in the control group (P<0.05)；After treatment，the left ventricular end systolic volume (LVESV) in the combined treatment group was significantly lower than that in the control group，and the left ventricular ejection fraction (LVEF) was significantly higher than that in the control group (P<0.05)；There was no significant difference in the incidence of adverse reactions between the two groups of patients during the administration period (P>0.05).Conclusion The combination of Yiqi Qiangxin decoction and Western medicine comprehensive treatment can improve the inflammatory response and oxidative stress response of patients with chronic heart failure，reduce endothelial damage，restore heart function，and basically do not increase adverse reactions.

参考文献/References:

[1］YAN YM，YE MF，DONG XF，et al.Prevention of contrast-induced nephropathy by inferior vena Cava ultrasonography-guided hydration in chronic heart failure patients[J].Cardiology，2021，146(2):187-194.
[2]PELLICORI P，CLELAND JGF，CLARK AL.Chronic obstructive pulmonary disease and heart failure[J].Heart Failure Clinics，2020，16(1):33-44.
[3]唐婉莹.益气活血利水法治疗慢性心力衰竭的疗效观察[J].现代中医药，2019，39(5):58-60，74.
[4]霍娟勇.益气强心汤治疗难治性心衰的疗效观察[J].陕西中医，2016，37(8):985-986.
[5]中华医学会心血管病学分会心力衰竭学组，中国医师协会心力衰竭专业委员会，中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志，2018，46(10):760-789.
[6]职利琴，黄家欣，裴纪文.芪甲五苓汤联合西药对心衰小鼠心脏超声相关指标的影响[J].陕西中医药大学学报，2018，41(5):119-122，128.
[7]高飞，付强，包书茵，等.中医药治疗慢性心力衰竭机制的研究进展[J].中医药信息，2022，39(5):85-89.
[8]任川明，曹启洪.曹启洪主任中医师辨治慢性心力衰竭的学术思想精要[J].中国中医急症，2022，31(9):1465-1466，1480.
[9]马嘉伟，刘福明.慢性心力衰竭的中医药研究进展[J].中国中医药现代远程教育，2022，20(9):201-204.
[10]王娟，赵慧辉，陈建新，等.慢性心力衰竭患者中医证候与原发病的相关性研究[J].国际中医中药杂志，2019，41(4):331-334.
[11]郭允，王学工.加味益气强心汤对心阳亏虚型慢性心衰患者心功能、血管内皮功能的影响[J].陕西中医，2021，42(4):456-458.
[12]孙梓宜，张天雅，王子涵，等.中医药治疗慢性心力衰竭的网络药理学研究进展[J].中西医结合心脑血管病杂志，2022，20(21):3922-3925.
[13]李岩，牛红.强心益气汤配合西药治疗慢性心力衰竭33例[J].陕西中医，2013，34(7):800.
[14]王超，张咪，赵丽萍，等.基于网络药理学研究黄芪抗动脉粥样硬化的作用机制[J].中成药，2022，44(3):987-994.
[15]张柂儇，刘海龙，王瑞琼，等.黄芪化学成分和药理作用及Q-marker预测分析[J].中国新药杂志，2023，32(4):410-419.
[16]曹新福，王鑫淼，刘红旭，等.基于网络药理学研究丹参-红花治疗冠心病的物质基础及作用机制[J].世界中医药，2022，17(16):2270-2275.
[17]董庆海，刘慧，刘俊丽，等.基于UPLC-Q/TOF MS及网络药理学的丹参川芎嗪注射液抗血瘀活性成分和机制研究[J].质谱学报，2021，42(1):24-35.
[18]杨琦，林英，李慧萍，等.老年心力衰竭患者血清TNF-α、IL-8、IL-10水平对病情的评估意义[J].中国老年学杂志，2022，42(13):3126-3128.
[19]韩玉明，阿孜古丽·阿布都热合曼.血清TNF-α、IL-1β、IL-17水平与类风湿关节炎患者并发动脉粥样硬化关系研究[J].国际检验医学杂志，2018，39(3):371-373.
[20]刘畅，张苗苗，刘丽.丹红注射液对老年心衰患者血清TNF-α NF-κB和IL-1β的影响研究[J].河北医学，2017，23(1):10-13.
[21]宋琳琳，薛一涛.心力衰竭氧化应激与中医药研究进展[J].世界中医药，2022，17(12):1769-1772，1777.
[22]龚帆影，杜玉颖，李佳，等.抗心衰方对慢性心力衰竭患者心功能及氧化应激功能的影响[J].南京中医药大学学报，2023，39(2):118-123.
[23]高峰，肖雪，于策，等.益气通脉方对气虚血瘀型慢性心力衰竭患者心肌重塑、氧化应激及血管内皮功能的影响[J].微循环学杂志，2022，32(2):40-44.
[24]祝德伟，李秋媛，杨朴强.中医药干预慢性心力衰竭机制探讨[J].中西医结合心脑血管病杂志，2022，20(16):3045-3047.
[25]庄海春，韩天雄，石红.苓桂术甘汤联合温针灸治疗慢性心力衰竭的疗效及对患者心功能和血管内皮功能的影响[J].海南医学，2022，33(17):2181-2184.

相似文献/References:

[1]唐婉莹.益气活血利水法治疗慢性心力衰竭的疗效观察[J].现代中医药,2019,(05):058.[doi:10.13424/j.cnki.mtcm.2019.05.018]
[2]夏柔娟 蒙广阔 *.心衰合剂治疗慢性心力衰竭临床疗效观察[J].现代中医药,2018,(06):009.[doi:10.13424/j.cnki.mtcm.2018.06.004]
　Xia Roujuan Meng Guangkuo.Clinical Observation of Heart Failure Mixture in Treating Chronic Heart Failure[J].Modern Traditional Chinese Medicine,2018,(03):009.[doi:10.13424/j.cnki.mtcm.2018.06.004]
[3]杨嘉豪 徐建虎.温阳消饮法对慢性心力衰竭模型 大鼠血清 ＡＮＰ、ＴＮＦ－α及 ＩＬ－６水平影响[J].现代中医药,2019,(02):092.[doi:10.13424/j.cnki.mtcm.2019.02.028]
　Yang Jiahao Xu Jianhu.Effect of the Therapy of Warming Yang to Resolve Fluid Retention on Serum ANP, TNF -α and IL -6 Levels in Rats with Chronic Heart Failure[J].Modern Traditional Chinese Medicine,2019,(03):092.[doi:10.13424/j.cnki.mtcm.2019.02.028]
[4]田 心.从中医“圆运动”谈慢性心力衰竭诊疗指南的药物应用[J].现代中医药,2021,(02):018.[doi:10.13424/j.cnki.mtct.2021.02.004]
　TIAN Xin.Discussion on Drug Application of Chronic Heart Failure Diagnosis and Treatment Guidelines from circular movement of Chinese Medicine[J].Modern Traditional Chinese Medicine,2021,(03):018.[doi:10.13424/j.cnki.mtct.2021.02.004]
[5]张军茹.中西医视角治疗慢性心力衰竭合并高尿酸血症探析[J].现代中医药,2021,(03):001.[doi:10.13424/j.cnki.mtcm.2021.03.001]
　ZHANGJunru.TreatmentofChronicHeartFailurewithHyperuricemiafromthePerspectiveofTraditionalChineseandWesternMedicine[J].Modern Traditional Chinese Medicine,2021,(03):001.[doi:10.13424/j.cnki.mtcm.2021.03.001]
[6]杜永波** 杨建伟 王梅梅 徐新松王洪杰.基于心功能及氧化应激指标探析附萸汤治疗慢性心力衰竭的有效性[J].现代中医药,2023,(05):074.[doi:10.13424/j.cnki.mtcm.2023.05.015]
　DU Yongbo YANG Jianwei WANG Meimei XU Xinsong WANG Hongjie.Effectiveness of Fuyu Decoction in Treating Chronic Heart FailureBased on Cardiac Function and Oxidative Stress Indicators[J].Modern Traditional Chinese Medicine,2023,(03):074.[doi:10.13424/j.cnki.mtcm.2023.05.015]
[7]王铭马立旭 王秀萍韩金荣 徐建虎.消饮化瘀方对慢性心力衰竭大鼠NTproBNP及GPR35mRNA水平的影响[J].现代中医药,2023,(05):113.[doi:10.13424/j.cnki.mtcm.2023.05.021]

备注/Memo

备注/Memo:
基金项目：陕西省重点研发计划项目（S2017-ZDYF-YBXM-SF-0221）
更新日期/Last Update: 2024-05-20